Damm, Peter
Mathiesen, Elisabeth R.
Article History
First Online: 7 April 2015
Competing interests
: P.D. and E.R.M. are participating in a multicentre, multinational observational study of the use of injectable hypoglycaemic agents in pregnant women with type 1 diabetes mellitus and type 2 diabetes mellitus in collaboration with Novo Nordisk. P.D. has received fees for giving talks for Novo Nordisk. E.R.M. has received fees for giving talks for Novo Nordisk, Sanofi-Aventis and Eli Lilly, E.R.M. has received a research grant from The Novo Nordisk Foundation.